Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LabTurbo BiotechROCO:7725 41 Gross Margin % is 22.71% as of Jun. 2026, which is 3% below its 10-year median of 23.33. GuruFocus rates ROCO:7725 with a GF Score™ of 41/100 and a GF Value™ of NT$28.69 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 737 Biotechnology companies, LabTurbo Biotech ranks worse than 91.86% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
LabTurbo Biotech had a gross margin of 22.71% for the quarter that ended in Jun. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
LabTurbo Biotech Gross Margin % Related Terms
LabTurbo Biotech Gross Margin % Historical Data
* Premium members only.
The historical data trend for LabTurbo Biotech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7725 vs VRTX, REGN, MRNA: Gross Margin % Comparison
For the Biotechnology subindustry, LabTurbo Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LabTurbo Biotech Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LabTurbo Biotech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where LabTurbo Biotech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
LabTurbo Biotech (ROCO:7725) has a Gross Margin % of 22.71% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on LabTurbo Biotech and its competitors. This is near median its historical median of 23.33. According to the industry distribution chart, LabTurbo Biotech ranks #677 out of 737 companies in the Biotechnology industry, placing it in the top 91.9%.
Is LabTurbo Biotech's Gross Margin % too high?
LabTurbo Biotech's current Gross Margin % of 22.71% is near median its 10-year median of 23.33. The Biotechnology industry median Gross Margin % is 61.00. LabTurbo Biotech's value of 22.71% is 62.8% below this industry median. Based on the distribution chart, LabTurbo Biotech ranks #677 out of 737 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, LabTurbo Biotech has a GF Score™ of 41/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LabTurbo Biotech's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, LabTurbo Biotech ranks #677 out of 737 companies for Gross Margin %. This places LabTurbo Biotech in the lower half of its industry. The industry median Gross Margin % is 61.00. LabTurbo Biotech's value of 22.71% is 62.8% below this benchmark. While the company's 10-year median is 23.33 vs. the industry median of 61.00, LabTurbo Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 61.00, based on 737 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LabTurbo Biotech's current Gross Margin % of 22.71% is 62.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on LabTurbo Biotech and its competitors. For the Biotechnology industry, the median Gross Margin % is 61.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LabTurbo Biotech's current Gross Margin % is 22.71%, which is near median its own 10-year median of 23.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LabTurbo Biotech stock overvalued right now?
Based on GuruFocus' analysis, LabTurbo Biotech (ROCO:7725) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$28.69, compared to a current price of NT$22.30 — trading 22.3% below its estimated fair value. The current Gross Margin % is 22.71%, which is near median its 10-year median of 23.33 and 62.8% below the Biotechnology industry median of 61.00. LabTurbo Biotech's overall GF Score™ is 41/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For LabTurbo Biotech (ROCO:7725), the current Gross Margin % is 22.71% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LabTurbo Biotech (ROCO:7725) Overvalued in 2026?
Based on GuruFocus' analysis, LabTurbo Biotech stock appears to be undervalued.
The current stock price of NT$22.30 is trading 22.3% below its estimated GF Value™ of NT$28.69.
GuruFocus considers LabTurbo Biotech to be Modestly Undervalued.
Key valuation signals for ROCO:7725:
Gross Margin %: 22.71% (near median its 10-year median of 23.33)
GF Value™: NT$28.69 vs. price of NT$22.30 (22.3% below fair value)
Industry Position: 62.8% below the Biotechnology median (#677 of 737)
No single metric tells the full story. See the ROCO:7725 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
41GF Score
Get the complete analysis for ROCO:7725
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7725 has been successfully added to your 
